These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
186 related articles for article (PubMed ID: 3891999)
21. [Glycosylated hemoglobin compared with blood glucose and lipid parameters in diabetics treated with an insulin preparation and diet]. Preradov-Mikić M Med Pregl; 1987; 40(3-4):105-9. PubMed ID: 3312983 [No Abstract] [Full Text] [Related]
22. The KID Study. III: Impact of inpatient rehabilitation on the metabolic control of type I and type II diabetics--a one-year follow-up. Haupt E; Herrmann R; Benecke-Timp A; Vogel H; Hilgenfeldt J; Haupt A; Walter C Exp Clin Endocrinol Diabetes; 1996; 104(6):420-30. PubMed ID: 9021342 [TBL] [Abstract][Full Text] [Related]
23. Comparison of metabolic and psychological parameters during continuous subcutaneous insulin infusion and intensified conventional insulin treatment in type I diabetic patients. Schottenfeld-Naor Y; Galatzer A; Karp M; Josefsberg Z; Laron Z Isr J Med Sci; 1985 Oct; 21(10):822-8. PubMed ID: 3908396 [TBL] [Abstract][Full Text] [Related]
24. Factors affecting glycosylated hemoglobin values in children with insulin-dependent diabetes. Daneman D; Wolfson DH; Becker DJ; Drash AL J Pediatr; 1981 Dec; 99(6):847-53. PubMed ID: 7031207 [TBL] [Abstract][Full Text] [Related]
25. Relationship between retinopathy and glycaemic control in insulin-dependent and non-insulin-dependent diabetes. Monson JP; Koios G; Toms GC; Kopelman PG; Boucher BJ; Evans SJ; Alexander WL J R Soc Med; 1986 May; 79(5):274-6. PubMed ID: 3723520 [TBL] [Abstract][Full Text] [Related]
26. Alpha 2-macroglobulin and proliferative retinopathy in type 1 diabetes. Gray RS; James K; Merriman J; Starkey IR; Elton RA; Clarke BF; Duncan LJ Horm Metab Res; 1982 Aug; 14(8):389-92. PubMed ID: 6182082 [TBL] [Abstract][Full Text] [Related]
27. Correlations between glycosylated haemoglobin and other metabolic parameters in insulin-dependent diabetics. Odetti P; Ansaldi E; Diara C; Cheli V; Andraghetti G; Buzzo P; Prando R Diabete Metab; 1983 Mar; 9(1):26-31. PubMed ID: 6343150 [TBL] [Abstract][Full Text] [Related]
28. Factors influencing preference of insulin regimen in people with type 1 (insulin-dependent) diabetes. Perros P; Deary IJ; Frier BM Diabetes Res Clin Pract; 1998 Jan; 39(1):23-9. PubMed ID: 9597371 [TBL] [Abstract][Full Text] [Related]
29. Relationship of glycosylated haemoglobin to C-peptide secretory status and antibody binding of insulin in insulin-dependent diabetes. Gray RS; Borsey DQ; Kurtz A; Rainbow S; Smith AF; Elton RA; Duncan LJ; Clarke BF Horm Metab Res; 1981 Nov; 13(11):599-603. PubMed ID: 7030898 [TBL] [Abstract][Full Text] [Related]
31. The management of severe brittle diabetes with "Infusaid" implantable pumps. Gill GV; Husband DJ; Wright PD; Sharpe G; Taylor R; Walford S; Marshall SM; Alberti KG Diabetes Res; 1986 Mar; 3(3):135-7. PubMed ID: 3709039 [TBL] [Abstract][Full Text] [Related]
32. [The influence of long-term therapy with the insulin pump (CSII) in patients with type 1 diabetes mellitus on metabolic compensation and on the incidence of hypoglycaemia. Comparison with intensified conventional insulin therapy (MDI)]. Olsovský J; Beránek M Vnitr Lek; 2007 Jun; 53(6):637-45. PubMed ID: 17702123 [TBL] [Abstract][Full Text] [Related]
33. A randomized trial of the efficacy and acceptability of a pen injector. Murray DP; Keenan P; Gayer E; Salmon P; Tomkin GH; Drury MI; O'Sullivan DJ Diabet Med; 1988 Nov; 5(8):750-4. PubMed ID: 2975567 [TBL] [Abstract][Full Text] [Related]
34. Continuous Glucose Monitoring vs Conventional Therapy for Glycemic Control in Adults With Type 1 Diabetes Treated With Multiple Daily Insulin Injections: The GOLD Randomized Clinical Trial. Lind M; Polonsky W; Hirsch IB; Heise T; Bolinder J; Dahlqvist S; Schwarz E; Ólafsdóttir AF; Frid A; Wedel H; Ahlén E; Nyström T; Hellman J JAMA; 2017 Jan; 317(4):379-387. PubMed ID: 28118454 [TBL] [Abstract][Full Text] [Related]
35. [Treatment and glycemic control of 1200 diabetic patients enrolled at the National Institute of Disease-Disability Insurance diabetes convention]. Buysschaert M; Maes M; Hermans MP Acta Clin Belg; 1997; 52(4):211-8. PubMed ID: 9412121 [TBL] [Abstract][Full Text] [Related]
36. Improvement of the compliance with blood glucose monitoring in young insulin-dependent diabetes mellitus patients by the Sensorlink system. Dorchy H; Roggemans MP Diabetes Res Clin Pract; 1997 May; 36(2):77-82. PubMed ID: 9229191 [TBL] [Abstract][Full Text] [Related]
37. Multiple daily insulin injections improve self-confidence. Houtzagers CM; Visser AP; Berntzen PA; van der Stap H; van Maarschalkerweerd WW; Heine RJ; van der Veen EA Diabet Med; 1989 Aug; 6(6):512-9. PubMed ID: 2527133 [TBL] [Abstract][Full Text] [Related]
38. Split-mixed insulin regimen with human ultralente before supper and NPH (isophane) before breakfast in children and adolescents with IDDM. Wolfsdorf JI; Laffel LM; Pasquarello C; Vernon A; Herskowitz RD Diabetes Care; 1991 Nov; 14(11):1100-6. PubMed ID: 1797498 [TBL] [Abstract][Full Text] [Related]
39. Transient improvement in glycemic control. The impact of pregnancy in women with IDDM. Gold AE; Reilly C; Walker JD Diabetes Care; 1998 Mar; 21(3):374-8. PubMed ID: 9540018 [TBL] [Abstract][Full Text] [Related]
40. [Effect of glipizide on glycemic control and peripheral insulin sensitivity in type 1 diabetics]. Leblanc H; Thote A; Chatellier G; Passa P Diabete Metab; 1990; 16(2):93-7. PubMed ID: 2196193 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]